E-resources
Peer reviewed
-
Laurent, Camille; Baron, Marine; Amara, Nadia; Haioun, Corinne; Dandoit, Mylène; Maynadié, Marc; Parrens, Marie; Vergier, Beatrice; Copie-Bergman, Christiane; Fabiani, Bettina; Traverse-Glehen, Alexandra; Brousse, Nicole; Copin, Marie-Christine; Tas, Patrick; Petrella, Tony; Rousselet, Marie-Christine; Brière, Josette; Charlotte, Fréderic; Chassagne-Clement, Catherine; Rousset, Thérèse; Xerri, Luc; Moreau, Anne; Martin, Antoine; Damotte, Diane; Dartigues, Peggy; Soubeyran, Isabelle; Peoch, Michel; Dechelotte, Pierre; Michiels, Jean-François; de Mascarel, Antoine; Berger, Françoise; Bossard, Céline; Arbion, Flavie; Quintin-Roué, Isabelle; Picquenot, Jean-Michel; Patey, Martine; Fabre, Blandine; Sevestre, Henri; Le Naoures, Cécile; Chenard-Neu, Marie-Pierre; Bastien, Claire; Thiebault, Sylvie; Martin, Laurent; Delage, Manuela; Filleron, Thomas; Salles, Gilles; Molina, Thierry Jo; Delsol, Georges; Brousset, Pierre; Gaulard, Philippe
Journal of clinical oncology, 06/2017, Volume: 35, Issue: 18Journal Article
Purpose To prospectively assess the clinical impact of expert review of lymphoma diagnosis in France. Materials and Methods From January 2010 to December 2013, 42,145 samples from patients with newly diagnosed or suspected lymphomas were reviewed, according to the 2008 WHO classification, in real time by experts through the Lymphopath Network. Changes in diagnosis between referral and expert review were classified as major or minor according to their potential impact on patient care. Results The 42,145 reviewed samples comprised 36,920 newly diagnosed mature lymphomas, 321 precursor lymphoid neoplasms, 314 myeloid disorders, and 200 nonhematopoietic neoplasms, with 4,390 benign lesions. There were 4,352 cutaneous and 32,568 noncutaneous lymphomas. The most common mature noncutaneous lymphomas were diffuse large B-cell lymphomas (32.4%), follicular lymphomas (15.3%), classic Hodgkin lymphomas (13%), peripheral T-cell lymphomas (6.3%) of which angioimmunoblastic T-cell lymphomas (2.3%) were the most frequent, and mucosa-associated lymphoid tissue lymphomas (5.8%). A diagnostic change between referral and expert review occurred in 19.7% of patients, with an estimated impact on patient care for 17.4% of patients. This rate was significantly higher for patients sent with a provisional diagnosis seeking expert second opinion (37.8%) than for patients sent with a formal diagnosis (3.7%). The most frequent discrepancies were misclassifications in lymphoma subtype (41.3%), with 12.3% being misclassifications among small B-cell lymphoma entities. Fewer than 2% of changes were between benign and malignant lymphoid conditions. Minor changes (2.3%) mostly consisted of follicular lymphoma misgrading and diffuse large B-cell lymphoma subtype misclassification. Conclusion To our knowledge, this study provides the largest ever description of the distribution of lymphoma entities in a western country and highlights how expert review significantly contributes to a precise lymphoma diagnosis and optimal clinical management in a proportion of patients.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.